HMT Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 9, 2025, 8:45 pm

Competitors of HMT Ltd

All Competitor Stocks of HMT Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:35 am

Below is a detailed analysis of the quarterly data for HMT Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 15.00 Cr..
• For Expenses, as of Jun 2025, the value is 46.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 104.00 Cr. (Mar 2025) to 46.00 Cr., marking a decrease of 58.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -21.00 Cr.. The value appears strong and on an upward trend. It has increased from -64.00 Cr. (Mar 2025) to -21.00 Cr., marking an increase of 43.00 Cr..
• For OPM %, as of Jun 2025, the value is -86.00%. The value appears strong and on an upward trend. It has increased from -162.00% (Mar 2025) to -86.00%, marking an increase of 76.00%.
• For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 39.00 Cr..
• For Interest, as of Jun 2025, the value is 18.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -28.00 Cr.. The value appears strong and on an upward trend. It has increased from -33.00 Cr. (Mar 2025) to -28.00 Cr., marking an increase of 5.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 9.00% (Mar 2025) to 0.00%, marking a decrease of 9.00%.
• For Net Profit, as of Jun 2025, the value is -28.00 Cr.. The value appears strong and on an upward trend. It has increased from -36.00 Cr. (Mar 2025) to -28.00 Cr., marking an increase of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.78. The value appears strong and on an upward trend. It has increased from -1.01 (Mar 2025) to -0.78, marking an increase of 0.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:11 am

Growth

Last Updated: September 5, 2025, 6:25 am

Balance Sheet

Last Updated: December 10, 2025, 2:48 am

Below is a detailed analysis of the balance sheet data for HMT Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 356.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 356.00 Cr..
• For Reserves, as of Sep 2025, the value is -2,322.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -2,254.00 Cr. (Mar 2025) to -2,322.00 Cr., marking a decline of 68.00 Cr..
• For Borrowings, as of Sep 2025, the value is 1,029.00 Cr.. The value remains steady. However, Reserves are negative, which is a major warning sign. There is no change compared to the previous period (Mar 2025) which recorded 1,029.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,458.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,413.00 Cr. (Mar 2025) to 1,458.00 Cr., marking an increase of 45.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 521.00 Cr.. The value appears to be improving (decreasing). It has decreased from 544.00 Cr. (Mar 2025) to 521.00 Cr., marking a decrease of 23.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 33.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 486.00 Cr.. The value appears to be declining and may need further review. It has decreased from 506.00 Cr. (Mar 2025) to 486.00 Cr., marking a decrease of 20.00 Cr..
• For Total Assets, as of Sep 2025, the value is 521.00 Cr.. The value appears to be declining and may need further review. It has decreased from 544.00 Cr. (Mar 2025) to 521.00 Cr., marking a decrease of 23.00 Cr..

However, the Borrowings (1,029.00 Cr.) are higher than the Reserves (-2,322.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for HMT Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -4.02. This value is below the healthy minimum of 5. It has decreased from 71.73 (Mar 24) to -4.02, marking a decrease of 75.75.
• For Diluted EPS (Rs.), as of Mar 25, the value is -4.02. This value is below the healthy minimum of 5. It has decreased from 71.73 (Mar 24) to -4.02, marking a decrease of 75.75.
• For Cash EPS (Rs.), as of Mar 25, the value is -3.81. This value is below the healthy minimum of 3. It has decreased from 71.96 (Mar 24) to -3.81, marking a decrease of 75.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -53.37. It has decreased from -49.27 (Mar 24) to -53.37, marking a decrease of 4.10.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -53.37. It has decreased from -49.27 (Mar 24) to -53.37, marking a decrease of 4.10.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4.00. It has decreased from 4.59 (Mar 24) to 4.00, marking a decrease of 0.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -1.77. This value is below the healthy minimum of 2. It has decreased from -1.59 (Mar 24) to -1.77, marking a decrease of 0.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.98. This value is below the healthy minimum of 0. It has decreased from -1.83 (Mar 24) to -1.98, marking a decrease of 0.15.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.94. This value is below the healthy minimum of 0. It has decreased from -3.74 (Mar 24) to -3.94, marking a decrease of 0.20.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -4.02. This value is below the healthy minimum of 2. It has decreased from 71.73 (Mar 24) to -4.02, marking a decrease of 75.75.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.02. This value is below the healthy minimum of 2. It has decreased from 71.73 (Mar 24) to -4.02, marking a decrease of 75.75.
• For PBDIT Margin (%), as of Mar 25, the value is -44.22. This value is below the healthy minimum of 10. It has decreased from -34.68 (Mar 24) to -44.22, marking a decrease of 9.54.
• For PBIT Margin (%), as of Mar 25, the value is -49.46. This value is below the healthy minimum of 10. It has decreased from -39.75 (Mar 24) to -49.46, marking a decrease of 9.71.
• For PBT Margin (%), as of Mar 25, the value is -98.41. This value is below the healthy minimum of 10. It has decreased from -81.40 (Mar 24) to -98.41, marking a decrease of 17.01.
• For Net Profit Margin (%), as of Mar 25, the value is -100.51. This value is below the healthy minimum of 5. It has decreased from 1,561.18 (Mar 24) to -100.51, marking a decrease of 1,661.69.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -100.52. This value is below the healthy minimum of 8. It has decreased from 1,561.18 (Mar 24) to -100.52, marking a decrease of 1,661.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -145.58 (Mar 24) to 0.00, marking an increase of 145.58.
• For Return on Capital Employeed (%), as of Mar 25, the value is 3.99. This value is below the healthy minimum of 10. It has increased from 3.78 (Mar 24) to 3.99, marking an increase of 0.21.
• For Return On Assets (%), as of Mar 25, the value is -27.20. This value is below the healthy minimum of 5. It has decreased from 422.58 (Mar 24) to -27.20, marking a decrease of 449.78.
• For Total Debt / Equity (X), as of Mar 25, the value is -0.54. This value is within the healthy range. It has increased from -0.60 (Mar 24) to -0.54, marking an increase of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.25. There is no change compared to the previous period (Mar 24) which recorded 0.25.
• For Current Ratio (X), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 1.5. It has decreased from 0.23 (Mar 24) to 0.20, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.16, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 4. It has increased from 0.76 (Mar 24) to 1.34, marking an increase of 0.58.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.90. This value is below the healthy minimum of 3. It has decreased from -0.83 (Mar 24) to -0.90, marking a decrease of 0.07.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.05. This value is below the healthy minimum of 3. It has decreased from -0.91 (Mar 24) to -1.05, marking a decrease of 0.14.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,530.28. It has increased from 2,353.54 (Mar 24) to 2,530.28, marking an increase of 176.74.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 17.78. This value exceeds the healthy maximum of 3. It has increased from 14.40 (Mar 24) to 17.78, marking an increase of 3.38.
• For EV / EBITDA (X), as of Mar 25, the value is -40.21. This value is below the healthy minimum of 5. It has increased from -41.53 (Mar 24) to -40.21, marking an increase of 1.32.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.99. This value exceeds the healthy maximum of 3. It has increased from 9.39 (Mar 24) to 11.99, marking an increase of 2.60.
• For Price / BV (X), as of Mar 25, the value is -0.89. This value is below the healthy minimum of 1. It has decreased from -0.87 (Mar 24) to -0.89, marking a decrease of 0.02.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 12.00. This value exceeds the healthy maximum of 3. It has increased from 9.39 (Mar 24) to 12.00, marking an increase of 2.61.
• For EarningsYield, as of Mar 25, the value is -0.08. This value is below the healthy minimum of 5. It has decreased from 1.66 (Mar 24) to -0.08, marking a decrease of 1.74.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness